Authors: Fenton, WS Dickerson, F Boronow, J Hibbeln, JR Knable, M

Citation: Ws. Fenton et al., A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia, AM J PSYCHI, 158(12), 2001, pp. 2071-2074

Authors: Torrey, EF Webster, M Knable, M Johnston, N Yolken, RH

Citation: Ef. Torrey et al., The Stanley Foundation brain collection and Neuropathology Consortium, SCHIZOPHR R, 44(2), 2000, pp. 151-155

Authors: Fenton, WS Hibbeln, J Knable, M

Citation: Ws. Fenton et al., Essential fatty acids, lipid membrane abnormalities, and the diagnosis andtreatment of schizophrenia, BIOL PSYCHI, 47(1), 2000, pp. 8-21

Authors: Torrey, F Jablensky, A Pearlson, G Knable, M",Adityanjee,"Ingraham, L Africa, B De Lisi, L Wildenauer, D Copolov, D Buka, S Murray, R Stevens, J Jones, P Rund, B Goldberg, T Gallhofer, B Falkai, P Tsuang, M Schroder, J Bogerts, B Friedman, L Bogerts, B Lawson, B Bachus, S Post, R Haas, G

Citation: F. Torrey et al., Stanley Foundation Satellite Symposium, Santa Fe, New Mexico, Saturday, April 17, 1999, SCHIZOPHR R, 39(2), 1999, pp. 159-163

Authors: Knable, M

Citation: M. Knable, Thioridazine for elderly patients with dementia - Comment, WEST J MED, 171(1), 1999, pp. 22-22